Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2014

01-01-2014 | Original Article

A frequent splicing mutation and novel missense mutations color the updated mutational spectrum of classic galactosemia in Portugal

Authors: Ana I. Coelho, Ruben Ramos, Ana Gaspar, Cláudia Costa, Anabela Oliveira, Luísa Diogo, Paula Garcia, Sandra Paiva, Esmeralda Martins, Elisa Leão Teles, Esmeralda Rodrigues, M. Teresa Cardoso, Elena Ferreira, Sílvia Sequeira, Margarida Leite, Maria João Silva, Isabel Tavares de Almeida, João B. Vicente, Isabel Rivera

Published in: Journal of Inherited Metabolic Disease | Issue 1/2014

Login to get access

Abstract

Classic galactosemia is an autosomal recessive disorder caused by deficient galactose-1-phosphate uridylyltransferase (GALT) activity. Patients develop symptoms in the neonatal period, which can be ameliorated by dietary restriction of galactose. Many patients develop long-term complications, with a broad range of clinical symptoms whose pathophysiology is poorly understood. The high allelic heterogeneity of GALT gene that characterizes this disorder is thought to play a determinant role in biochemical and clinical phenotypes. We aimed to characterize the mutational spectrum of GALT deficiency in Portugal and to assess potential genotype-phenotype correlations. Direct sequencing of the GALT gene and in silico analyses were employed to evaluate the impact of uncharacterized mutations upon GALT functionality. Molecular characterization of 42 galactosemic Portuguese patients revealed a mutational spectrum comprising 14 nucleotide substitutions: ten missense, two nonsense and two putative splicing mutations. Sixteen different genotypic combinations were detected, half of the patients being p.Q188R homozygotes. Notably, the second most frequent variation is a splicing mutation. In silico predictions complemented by a close-up on the mutations in the protein structure suggest that uncharacterized missense mutations have cumulative point effects on protein stability, oligomeric state, or substrate binding. One splicing mutation is predicted to cause an alternative splicing event. This study reinforces the difficulty in establishing a genotype-phenotype correlation in classic galactosemia, a monogenic disease whose complex pathogenesis and clinical features emphasize the need to expand the knowledge on this “cloudy” disorder.
Appendix
Available only for authorised users
Literature
go back to reference Arnaiz-Villena A, Martinez-Laso J, Gomez-Casado E et al (1997) Relatedness among Basques, Portuguese, Spaniards, and Algerians studied by HLA allelic frequencies and haplotypes. Immunogenetics 47(1):37–43PubMedCrossRef Arnaiz-Villena A, Martinez-Laso J, Gomez-Casado E et al (1997) Relatedness among Basques, Portuguese, Spaniards, and Algerians studied by HLA allelic frequencies and haplotypes. Immunogenetics 47(1):37–43PubMedCrossRef
go back to reference Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22(2):195–201PubMedCrossRef Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22(2):195–201PubMedCrossRef
go back to reference Brunak S, Engelbrecht J, Knudsen S (1991) Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 220(1):49–65PubMedCrossRef Brunak S, Engelbrecht J, Knudsen S (1991) Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 220(1):49–65PubMedCrossRef
go back to reference Calderon FR, Phansalkar AR, Crockett DK, Miller M, Mao R (2007) Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene. Hum Mutat 28(10):939–943PubMedCrossRef Calderon FR, Phansalkar AR, Crockett DK, Miller M, Mao R (2007) Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene. Hum Mutat 28(10):939–943PubMedCrossRef
go back to reference Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31(13):3568–3571PubMedCentralPubMedCrossRef Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31(13):3568–3571PubMedCentralPubMedCrossRef
go back to reference Chhay JS, Openo KK, Eaton JS, Gentile M, Fridovich-Keil JL (2008) A yeast model reveals biochemical severity associated with each of three variant alleles of galactose-1P uridylyltransferase segregating in a single family. J Inherit Metab Dis 31(1):97–107PubMedCrossRef Chhay JS, Openo KK, Eaton JS, Gentile M, Fridovich-Keil JL (2008) A yeast model reveals biochemical severity associated with each of three variant alleles of galactose-1P uridylyltransferase segregating in a single family. J Inherit Metab Dis 31(1):97–107PubMedCrossRef
go back to reference Crews C, Wilkinson KD, Wells L, Perkins C, Fridovich-Keil JL (2000) Functional consequence of substitutions at residue 171 in human galactose-1-phosphate uridylyltransferase. J Biol Chem 275(30):22847–22853PubMedCrossRef Crews C, Wilkinson KD, Wells L, Perkins C, Fridovich-Keil JL (2000) Functional consequence of substitutions at residue 171 in human galactose-1-phosphate uridylyltransferase. J Biol Chem 275(30):22847–22853PubMedCrossRef
go back to reference Crushell E, Chukwu J, Mayne P, Blatny J, Treacy EP (2009) Negative screening tests in classical galactosaemia caused by S135L homozygosity. J Inherit Metab Dis 32(3):412–415PubMedCrossRef Crushell E, Chukwu J, Mayne P, Blatny J, Treacy EP (2009) Negative screening tests in classical galactosaemia caused by S135L homozygosity. J Inherit Metab Dis 32(3):412–415PubMedCrossRef
go back to reference Dehouck Y, Kwasigroch JM, Gilis D, Rooman M (2011) PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality. BMC Bioinforma 12:151CrossRef Dehouck Y, Kwasigroch JM, Gilis D, Rooman M (2011) PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality. BMC Bioinforma 12:151CrossRef
go back to reference Elsas LJ, Lai K, Saunders CJ, Langley SD (2001) Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 72(4):297–305PubMedCrossRef Elsas LJ, Lai K, Saunders CJ, Langley SD (2001) Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 72(4):297–305PubMedCrossRef
go back to reference Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297(5583):1007–1013PubMedCrossRef Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297(5583):1007–1013PubMedCrossRef
go back to reference Flanagan JM, McMahon G, Brendan Chia SH et al (2010) The role of human demographic history in determining the distribution and frequency of transferase-deficient galactosaemia mutations. Heredity (Edinb) 104(2):148–154CrossRef Flanagan JM, McMahon G, Brendan Chia SH et al (2010) The role of human demographic history in determining the distribution and frequency of transferase-deficient galactosaemia mutations. Heredity (Edinb) 104(2):148–154CrossRef
go back to reference Fridovich-Keil JL (2006) Galactosemia: the good, the bad, and the unknown. J Cell Physiol 209(3):701–705PubMedCrossRef Fridovich-Keil JL (2006) Galactosemia: the good, the bad, and the unknown. J Cell Physiol 209(3):701–705PubMedCrossRef
go back to reference Fridovich-Keil J, Walter JH (2008). Galactosemia. In: Valle D, Beaudet AL, Vogelstein B et al (eds) The online metabolic and molecular bases of inherited diseases (OMMBID). McGraw Hill, New York, pp 1–108 Fridovich-Keil J, Walter JH (2008). Galactosemia. In: Valle D, Beaudet AL, Vogelstein B et al (eds) The online metabolic and molecular bases of inherited diseases (OMMBID). McGraw Hill, New York, pp 1–108
go back to reference Fridovich-Keil JL, Langley SD, Mazur LA, Lennon JC, Dembure PP, Elsas JL 2nd (1995) Identification and functional analysis of three distinct mutations in the human galactose-1-phosphate uridyltransferase gene associated with galactosemia in a single family. Am J Hum Genet 56(3):640–646PubMedCentralPubMed Fridovich-Keil JL, Langley SD, Mazur LA, Lennon JC, Dembure PP, Elsas JL 2nd (1995) Identification and functional analysis of three distinct mutations in the human galactose-1-phosphate uridyltransferase gene associated with galactosemia in a single family. Am J Hum Genet 56(3):640–646PubMedCentralPubMed
go back to reference Geeganage S, Frey PA (1998) Transient kinetics of formation and reaction of the uridylyl-enzyme form of galactose-1-P uridylyltransferase and its Q168R-variant: insight into the molecular basis of galactosemia. Biochemistry 37(41):14500–14507PubMedCrossRef Geeganage S, Frey PA (1998) Transient kinetics of formation and reaction of the uridylyl-enzyme form of galactose-1-P uridylyltransferase and its Q168R-variant: insight into the molecular basis of galactosemia. Biochemistry 37(41):14500–14507PubMedCrossRef
go back to reference Gitzelmann R (1969) Estimation of galactose-I-phosphate in erythrocytes: a rapid and simple enzymatic method. Clin Chim Acta 26(2):313–316PubMedCrossRef Gitzelmann R (1969) Estimation of galactose-I-phosphate in erythrocytes: a rapid and simple enzymatic method. Clin Chim Acta 26(2):313–316PubMedCrossRef
go back to reference Gonnelli G, Rooman M, Dehouck Y (2012) Structure-based mutant stability predictions on proteins of unknown structure. J Biotechnol 161(3):287–293PubMedCrossRef Gonnelli G, Rooman M, Dehouck Y (2012) Structure-based mutant stability predictions on proteins of unknown structure. J Biotechnol 161(3):287–293PubMedCrossRef
go back to reference Gort L, Boleda MD, Tyfield L et al (2006) Mutational spectrum of classical galactosaemia in Spain and Portugal. J Inherit Metab Dis 29(6):739–742PubMedCrossRef Gort L, Boleda MD, Tyfield L et al (2006) Mutational spectrum of classical galactosaemia in Spain and Portugal. J Inherit Metab Dis 29(6):739–742PubMedCrossRef
go back to reference Gort L, Quintana E, Moliner S, Gonzalez-Quereda L, Lopez-Hernandez T, Briones P (2009) An update on the molecular analysis of classical galactosaemia patients diagnosed in Spain and Portugal: 7 new mutations in 17 new families. Med Clin (Barc) 132(18):709–711CrossRef Gort L, Quintana E, Moliner S, Gonzalez-Quereda L, Lopez-Hernandez T, Briones P (2009) An update on the molecular analysis of classical galactosaemia patients diagnosed in Spain and Portugal: 7 new mutations in 17 new families. Med Clin (Barc) 132(18):709–711CrossRef
go back to reference Gregoret LM, Rader SD, Fletterick RJ, Cohen FE (1991) Hydrogen bonds involving sulfur atoms in proteins. Proteins 9(2):99–107PubMedCrossRef Gregoret LM, Rader SD, Fletterick RJ, Cohen FE (1991) Hydrogen bonds involving sulfur atoms in proteins. Proteins 9(2):99–107PubMedCrossRef
go back to reference Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J, Rouze P, Brunak S (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24(17):3439–3452PubMedCentralPubMedCrossRef Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J, Rouze P, Brunak S (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24(17):3439–3452PubMedCentralPubMedCrossRef
go back to reference Henderson H, Leisegang F, Brown R, Eley B (2002) The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa. BMC Pediatr 2:7PubMedCentralPubMedCrossRef Henderson H, Leisegang F, Brown R, Eley B (2002) The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa. BMC Pediatr 2:7PubMedCentralPubMedCrossRef
go back to reference Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T (2009) The SWISS-MODEL repository and associated resources. Nucleic Acids Res 37(Database issue):D387–D392PubMedCentralPubMedCrossRef Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T (2009) The SWISS-MODEL repository and associated resources. Nucleic Acids Res 37(Database issue):D387–D392PubMedCentralPubMedCrossRef
go back to reference Lai K, Langley SD, Singh RH, Dembure PP, Hjelm LN, Elsas LJ 2nd (1996) A prevalent mutation for galactosemia among black Americans. J Pediatr 128(1):89–95PubMedCrossRef Lai K, Langley SD, Singh RH, Dembure PP, Hjelm LN, Elsas LJ 2nd (1996) A prevalent mutation for galactosemia among black Americans. J Pediatr 128(1):89–95PubMedCrossRef
go back to reference Leslie ND, Immerman EB, Flach JE, Florez M, Fridovich-Keil JL, Elsas LJ (1992) The human galactose-1-phosphate uridyltransferase gene. Genomics 14(2):474–480PubMedCrossRef Leslie ND, Immerman EB, Flach JE, Florez M, Fridovich-Keil JL, Elsas LJ (1992) The human galactose-1-phosphate uridyltransferase gene. Genomics 14(2):474–480PubMedCrossRef
go back to reference Lindhout M, Rubio-Gozalbo ME, Bakker JA, Bierau J (2010) Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography. Clin Chim Acta 411(13–14):980–983PubMedCrossRef Lindhout M, Rubio-Gozalbo ME, Bakker JA, Bierau J (2010) Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography. Clin Chim Acta 411(13–14):980–983PubMedCrossRef
go back to reference Lukac-Bajalo J, Kuzelicki NK, Zitnik IP, Mencej S, Battelino T (2007) Higher frequency of the galactose-1-phosphate uridyl transferase gene K285N mutation in the Slovenian population. Clin Biochem 40(5–6):414–415PubMedCrossRef Lukac-Bajalo J, Kuzelicki NK, Zitnik IP, Mencej S, Battelino T (2007) Higher frequency of the galactose-1-phosphate uridyl transferase gene K285N mutation in the Slovenian population. Clin Biochem 40(5–6):414–415PubMedCrossRef
go back to reference Marabotti A, Facchiano AM (2005) Homology modeling studies on human galactose-1-phosphate uridylyltransferase and on its galactosemia-related mutant Q188R provide an explanation of molecular effects of the mutation on homo- and heterodimers. J Med Chem 48(3):773–779PubMedCrossRef Marabotti A, Facchiano AM (2005) Homology modeling studies on human galactose-1-phosphate uridylyltransferase and on its galactosemia-related mutant Q188R provide an explanation of molecular effects of the mutation on homo- and heterodimers. J Med Chem 48(3):773–779PubMedCrossRef
go back to reference McCorvie TJ, Timson DJ (2011) The structural and molecular biology of type I galactosemia: enzymology of galactose 1-phosphate uridylyltransferase. IUBMB Life 63(9):694–700PubMed McCorvie TJ, Timson DJ (2011) The structural and molecular biology of type I galactosemia: enzymology of galactose 1-phosphate uridylyltransferase. IUBMB Life 63(9):694–700PubMed
go back to reference Parthiban V, Gromiha MM, Schomburg D (2006) CUPSAT: prediction of protein stability upon point mutations. Nucleic Acids Res 34(Web Server issue):W239–W242PubMedCentralPubMedCrossRef Parthiban V, Gromiha MM, Schomburg D (2006) CUPSAT: prediction of protein stability upon point mutations. Nucleic Acids Res 34(Web Server issue):W239–W242PubMedCentralPubMedCrossRef
go back to reference Parthiban V, Gromiha MM, Abhinandan M, Schomburg D (2007) Computational modeling of protein mutant stability: analysis and optimization of statistical potentials and structural features reveal insights into prediction model development. BMC Struct Biol 7:54PubMedCentralPubMedCrossRef Parthiban V, Gromiha MM, Abhinandan M, Schomburg D (2007) Computational modeling of protein mutant stability: analysis and optimization of statistical potentials and structural features reveal insights into prediction model development. BMC Struct Biol 7:54PubMedCentralPubMedCrossRef
go back to reference Perez B, Desviat LR, Ugarte M (1997) Analysis of the phenylalanine hydroxylase gene in the Spanish population: mutation profile and association with intragenic polymorphic markers. Am J Hum Genet 60(1):95–102PubMedCentralPubMed Perez B, Desviat LR, Ugarte M (1997) Analysis of the phenylalanine hydroxylase gene in the Spanish population: mutation profile and association with intragenic polymorphic markers. Am J Hum Genet 60(1):95–102PubMedCentralPubMed
go back to reference Quimby BB, Wells L, Wilkinson KD, Fridovich-Keil JL (1996) Functional requirements of the active site position 185 in the human enzyme galactose-1-phosphate uridylyltransferase. J Biol Chem 271(43):26835–26842PubMedCrossRef Quimby BB, Wells L, Wilkinson KD, Fridovich-Keil JL (1996) Functional requirements of the active site position 185 in the human enzyme galactose-1-phosphate uridylyltransferase. J Biol Chem 271(43):26835–26842PubMedCrossRef
go back to reference Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4(3):311–323PubMedCrossRef Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4(3):311–323PubMedCrossRef
go back to reference Reichardt JK, Berg P (1988) Cloning and characterization of a cDNA encoding human galactose-1-phosphate uridyl transferase. Mol Biol Med 5(2):107–122PubMed Reichardt JK, Berg P (1988) Cloning and characterization of a cDNA encoding human galactose-1-phosphate uridyl transferase. Mol Biol Med 5(2):107–122PubMed
go back to reference Reichardt JK, Woo SL (1991) Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci U S A 88(7):2633–2637PubMedCentralPubMedCrossRef Reichardt JK, Woo SL (1991) Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci U S A 88(7):2633–2637PubMedCentralPubMedCrossRef
go back to reference Riehman K, Crews C, Fridovich-Keil JL (2001) Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. J Biol Chem 276(14):10634–10640PubMedCrossRef Riehman K, Crews C, Fridovich-Keil JL (2001) Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. J Biol Chem 276(14):10634–10640PubMedCrossRef
go back to reference Rivera I, Leandro P, Lichter-Konecki U, Tavares de Almeida I, Lechner MC (1998) Population genetics of hyperphenylalaninaemia resulting from phenylalanine hydroxylase deficiency in Portugal. J Med Genet 35(4):301–304PubMedCrossRef Rivera I, Leandro P, Lichter-Konecki U, Tavares de Almeida I, Lechner MC (1998) Population genetics of hyperphenylalaninaemia resulting from phenylalanine hydroxylase deficiency in Portugal. J Med Genet 35(4):301–304PubMedCrossRef
go back to reference Shield JP, Wadsworth EJ, MacDonald A et al (2000) The relationship of genotype to cognitive outcome in galactosaemia. Arch Dis Child 83(3):248–250PubMedCrossRef Shield JP, Wadsworth EJ, MacDonald A et al (2000) The relationship of genotype to cognitive outcome in galactosaemia. Arch Dis Child 83(3):248–250PubMedCrossRef
go back to reference Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15(16):2490–2508PubMedCrossRef Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15(16):2490–2508PubMedCrossRef
go back to reference Sommer M, Gathof BS, Podskarbi T, Giugliani R, Kleinlein B, Shin YS (1995) Mutations in the galactose-1-phosphate uridyltransferase gene of two families with mild galactosaemia variants. J Inherit Metab Dis 18(5):567–576PubMedCrossRef Sommer M, Gathof BS, Podskarbi T, Giugliani R, Kleinlein B, Shin YS (1995) Mutations in the galactose-1-phosphate uridyltransferase gene of two families with mild galactosaemia variants. J Inherit Metab Dis 18(5):567–576PubMedCrossRef
go back to reference Suzuki M, West C, Beutler E (2001) Large-scale molecular screening for galactosemia alleles in a pan-ethnic population. Hum Genet 109(2):210–215PubMedCrossRef Suzuki M, West C, Beutler E (2001) Large-scale molecular screening for galactosemia alleles in a pan-ethnic population. Hum Genet 109(2):210–215PubMedCrossRef
go back to reference Thoden JB, Ruzicka FJ, Frey PA, Rayment I, Holden HM (1997) Structural analysis of the H166G site-directed mutant of galactose-1-phosphate uridylyltransferase complexed with either UDP-glucose or UDP-galactose: detailed description of the nucleotide sugar binding site. Biochemistry 36(6):1212–1222PubMedCrossRef Thoden JB, Ruzicka FJ, Frey PA, Rayment I, Holden HM (1997) Structural analysis of the H166G site-directed mutant of galactose-1-phosphate uridylyltransferase complexed with either UDP-glucose or UDP-galactose: detailed description of the nucleotide sugar binding site. Biochemistry 36(6):1212–1222PubMedCrossRef
go back to reference Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25(24):4876–4882PubMedCentralPubMedCrossRef Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25(24):4876–4882PubMedCentralPubMedCrossRef
go back to reference Tyfield LA (2000) Galactosaemia and allelic variation at the galactose-1-phosphate uridyltransferase gene: a complex relationship between genotype and phenotype. Eur J Pediatr 159(Suppl 3):S204–S207PubMedCrossRef Tyfield LA (2000) Galactosaemia and allelic variation at the galactose-1-phosphate uridyltransferase gene: a complex relationship between genotype and phenotype. Eur J Pediatr 159(Suppl 3):S204–S207PubMedCrossRef
go back to reference Tyfield L, Reichardt J, Fridovich-Keil J et al (1999) Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat 13(6):417–430PubMedCrossRef Tyfield L, Reichardt J, Fridovich-Keil J et al (1999) Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat 13(6):417–430PubMedCrossRef
go back to reference Wells L, Fridovich-Keil JL (1997) Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia. J Inherit Metab Dis 20(5):633–642PubMedCrossRef Wells L, Fridovich-Keil JL (1997) Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia. J Inherit Metab Dis 20(5):633–642PubMedCrossRef
go back to reference Woodcock J (2007) The prospects for “personalized medicine” in drug development and drug therapy. Clin Pharmacol Ther 81(2):164–169PubMedCrossRef Woodcock J (2007) The prospects for “personalized medicine” in drug development and drug therapy. Clin Pharmacol Ther 81(2):164–169PubMedCrossRef
go back to reference Worth CL, Bickerton GR, Schreyer A et al (2007) A structural bioinformatics approach to the analysis of nonsynonymous single nucleotide polymorphisms (nsSNPs) and their relation to disease. J Bioinforma Comput Biol 5(6):1297–1318CrossRef Worth CL, Bickerton GR, Schreyer A et al (2007) A structural bioinformatics approach to the analysis of nonsynonymous single nucleotide polymorphisms (nsSNPs) and their relation to disease. J Bioinforma Comput Biol 5(6):1297–1318CrossRef
Metadata
Title
A frequent splicing mutation and novel missense mutations color the updated mutational spectrum of classic galactosemia in Portugal
Authors
Ana I. Coelho
Ruben Ramos
Ana Gaspar
Cláudia Costa
Anabela Oliveira
Luísa Diogo
Paula Garcia
Sandra Paiva
Esmeralda Martins
Elisa Leão Teles
Esmeralda Rodrigues
M. Teresa Cardoso
Elena Ferreira
Sílvia Sequeira
Margarida Leite
Maria João Silva
Isabel Tavares de Almeida
João B. Vicente
Isabel Rivera
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 1/2014
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9623-1

Other articles of this Issue 1/2014

Journal of Inherited Metabolic Disease 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine